跳至主要内容
临床试验/NCT06062472
NCT06062472已完成不适用

Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly

Chi-Chang Huang2 个研究点 分布在 1 个国家目标入组 119 人开始时间: 2023年8月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
119
试验地点
2
主要终点
30 seconds chair stand test

研究概览

简要总结

This study refers to the supplementation of PS23 in human experiments to help the elderly maintain muscle mass, delay muscle loss, promote physical activity, and delay the occurrence of disability and debilitation in elderly people.

详细描述

Taiwan has become an aging society in recent years. There are important issues to attenuate aging and activate the potential capacity of elderly population. The physical function of middle-aged and older people will degenerate with age and produce age-related diseases. Common symptoms are organ function deterioration, and old age disability caused by malnutrition and muscle loss is also a common care problem. Therefore, how to prevent the complications of muscle loss is one of the important ten years of geriatric research. Although past research has been confirmed, it can improve the debilitating condition of the elderly through nutrition counseling and exercise intervention. However, there is not much in-depth discussion on how probiotics can improve muscle loss and delay symptoms in elderly people. Therefore, this study refers to the supplementation of PS23 in human experiments to help the elderly maintain muscle mass, delay muscle loss, promote physical activity, and delay the occurrence of disability and debilitation in elderly people. One hundred and twenty elderly people will be recruited and then divided into three groups with 40 people in each group: (A) placebo group, (B) PS23 probiotic group, (C) PS23-HT prebiotic group, supplemented for 12 weeks. The diet record, functional test and muscle mass will be carried out every six weeks after the start, to understand whether PS23 is effective in improving muscle loss and weakness in elderly people.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 85 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • age between 65 and 85 years old

排除标准

  • Have taken antibiotics within one month or are receiving antibiotic treatment
  • Have used probiotic products in powder, capsule or tablet form within two weeks (except for yogurt, yogurt, Yakut and other related foods)
  • People allergic to lactic acid bacteria products
  • Patients diagnosed with stroke or hypertension (systolic blood pressure greater than 139, diastolic blood pressure greater than 89)
  • Exclusion of limbs and hips that have been replaced with artificial joints
  • Persons with incapacity/insufficient decision-making ability
  • Who has been determines that it is not suitable to participate in the research.

结局指标

主要结局

30 seconds chair stand test

时间窗: From Baseline, 6 weeks and 12 Weeks Assessed

30 seconds chair stand test will be used as a self-test. Number of stands will be counted.

muscle mass

时间窗: From Baseline, 6 weeks and 12 Weeks Assessed

Use dual-energy X-ray absorptiometry, DXA (Lunar iDXA, GE Healthcare, IL, USA) for no-entry measurement to determine muscle mass

Grip strength

时间窗: From Baseline, 6 weeks and 12 Weeks Assessed

Use the armed grip machine to measure, hold each of the left and right hands three times until they are weak, and record the maximum value

次要结局

  • Stress assessment - difference of Testosterone level(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Gut microbiota(From Baseline 12 Weeks Assessed)
  • Visual Analogue Scale for GI symptoms, VAS-GI(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Get Up and Go test(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Sit and Reach Test(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Safety assessment - Bun(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Q-LES-Q(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Safety assessment - AST(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Safety assessment - ALT(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Change in Insulin Sensitivity(From Baseline, 6 weeks and 12 Weeks Assessed)
  • fat percentage(From Baseline, 6 weeks and 12 Weeks Assessed)
  • One-leg stance test(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Safety assessment - Creatinine(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Difference in Oxidative stress - blood level of HSCRP(From Baseline, 6 weeks and 12 Weeks Assessed)
  • The serum IL-6 level(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Generalized Anxiety Disorder 7-Item, GAD-7(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Geriatric Depression Scale, GDS(From Baseline, 6 weeks and 12 Weeks Assessed)
  • PGI-C(From Baseline to 12 Weeks Assessed)
  • 10 meter walk(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Cardiorespiratory fitness(From Baseline, 6 weeks and 12 Weeks Assessed)
  • Level of Growth Differentiation Factor-15(From Baseline, 6 weeks and 12 Weeks Assessed)
  • TNF-a determination using ELISA(From Baseline, 6 weeks and 12 Weeks Assessed)

研究者

发起方
Chi-Chang Huang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Chi-Chang Huang

Principal Investigator

National Taiwan Sport University

研究点 (2)

Loading locations...

相似试验

Effect of Lactobacillus Paracasei PS23 on Improving... | 临床试验